Your browser doesn't support javascript.
loading
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Tacconelli, Evelina; Carrara, Elena; Savoldi, Alessia; Harbarth, Stephan; Mendelson, Marc; Monnet, Dominique L; Pulcini, Céline; Kahlmeter, Gunnar; Kluytmans, Jan; Carmeli, Yehuda; Ouellette, Marc; Outterson, Kevin; Patel, Jean; Cavaleri, Marco; Cox, Edward M; Houchens, Chris R; Grayson, M Lindsay; Hansen, Paul; Singh, Nalini; Theuretzbacher, Ursula; Magrini, Nicola.
Afiliação
  • Tacconelli E; German Centre for Infection Research, Tübingen University Hospital, Tübingen, Germany; Verona University Hospital, Verona, Italy. Electronic address: evelina.tacconelli@med.uni-tuebingen.de.
  • Carrara E; German Centre for Infection Research, Tübingen University Hospital, Tübingen, Germany; Verona University Hospital, Verona, Italy.
  • Savoldi A; German Centre for Infection Research, Tübingen University Hospital, Tübingen, Germany.
  • Harbarth S; World Health Organization Collaborating Centre on Patient Safety, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
  • Mendelson M; Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
  • Monnet DL; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Pulcini C; EA 4360 APEMAC, Nancy University Hospital, Lorraine University, Nancy, France.
  • Kahlmeter G; Central Hospital, Växjö, Sweden.
  • Kluytmans J; University Medical Center, Utrecht, Netherlands; Amphia Hospital, Breda, Netherlands.
  • Carmeli Y; Laboratory for Microbiology and Infection Control, Tel Aviv University, Tel Aviv, Israel.
  • Ouellette M; Laval University and Canadian Institutes for Health Research, Québec, QC, Canada.
  • Outterson K; Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator CARB-X, Boston University, Boston, MA, USA.
  • Patel J; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Cavaleri M; European Medicines Agency, London, UK.
  • Cox EM; US Food and Drug Administration, Washington, DC, USA.
  • Houchens CR; Antibacterials Program Biomedical Advanced Research and Development Authority, Washington, DC, USA.
  • Grayson ML; Austin Health, University of Melbourne, Melbourne, VIC, Australia.
  • Hansen P; Department of Infectious Diseases and Microbiology, University of Otago, Dunedin, New Zealand.
  • Singh N; Children's National Health System, George Washington University, Washington, DC, USA.
  • Theuretzbacher U; Center for Anti-infective Agents, Vienna, Austria.
  • Magrini N; Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland.
Lancet Infect Dis ; 18(3): 318-327, 2018 03.
Article em En | MEDLINE | ID: mdl-29276051
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Antibacterianos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Antibacterianos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos